By analyzing epigenomic and gene expression changes that occur in Alzheimer’s disease, researchers identify cellular pathways that could become new drug targets.
Researchers use multiple AI models to collaborate, debate, and improve their reasoning abilities to advance the performance of LLMs while increasing accountability and factual accuracy.